does tirzepatide slow gastric emptying Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions Media Centre | EASD

Studies reveal notable improvements in various conditions from neurodegenerative diseases to metabolic disorders

Not approved by FDA/EMA

For example, if there's a non active ingredient present in the generic which wasn't present in the brand name drug and there's no other generic available without that non active ingredient

MIC injections make it easier for your body to access stored fat and use it as a fuel source, promoting visible results

NO APPROVED THERAPEUTIC CLAIMS.

If you've reached therapeutic semaglutide doses (2.0-2.4 mg weekly) and weight loss stalls for more than 4 weeks, tirzepatide may unlock the next phase of results